Antares Pharma Inc  

(Public, NASDAQ:ATRS)   Watch this stock  
Find more results for James Garrity
-0.069 (-7.09%)
After Hours: 0.900 0.000 (0.00%)
Feb 10, 4:00PM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 0.89 - 1.01
52 week 0.88 - 3.04
Open 0.97
Vol / Avg. 689,588.00/1.07M
Mkt cap 136.64M
P/E     -
Div/yield     -
EPS -0.18
Shares 154.83M
Beta 0.72
Inst. own 42%
Mar 10, 2016
Q4 2015 Antares Pharma Inc Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Jan 14, 2016
Antares Pharma Inc at JPMorgan Healthcare Conference
Dec 9, 2015
Antares Pharma Inc at Oppenheimer Healthcare Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin -51.76% -132.64%
Operating margin -52.03% -132.49%
EBITD margin - -127.88%
Return on average assets -26.30% -44.58%
Return on average equity -30.69% -62.82%
Employees 93 -
CDP Score - -


EWING, NJ 8628
United States - Map
+1-609-3593020 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Antares Pharma, Inc. (Antares) is a specialty pharmaceutical Company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops and manufactures for itself and with partners, pressure-assisted injectors, with and without needles, which allow patients to self-inject drugs. It has developed variations of the needle-free injector by adding a small shielded needle to a pre-filled, single-use disposable injector, called the Vibex pressure assisted auto injection system. This system is an alternative to the needle-free system for use with injectable drugs in unit dose containers and is suitable for branded and generic injectables. It has also developed a disposable multi-dose pen injector for use with standard cartridges.

Officers and directors

Leonard S. Jacob M.D., Ph.D. Independent Chairman of the Board
Age: 66
Bio & Compensation  - Reuters
Robert F. Apple CPA President, Chief Executive Officer
Age: 48
Bio & Compensation  - Reuters
James E. Fickenscher Chief Financial Officer, Senior Vice President
Age: 51
Bio & Compensation  - Reuters
Peter J. Graham Esq., Senior Vice President, General Counsel, Human Resources, Chief Compliance Officer
Age: 47
Bio & Compensation  - Reuters
Thomas J. Garrity Independent Director
Age: 66
Bio & Compensation  - Reuters
Jacques Gonella Ph.D. Independent Director
Age: 73
Bio & Compensation  - Reuters
Anton G. Gueth Independent Director
Age: 58
Bio & Compensation  - Reuters
Robert P. Roche Jr. Independent Director
Age: 59
Bio & Compensation  - Reuters
Marvin S. Samson Independent Director
Age: 67
Bio & Compensation  - Reuters